SCHEMBL1967495

SCHEMBL1967495

CN(C1CCCNC1)S(C)(=O)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APLNR P35414 2/20 0.41
SLC6A2 P23975 7/20 0.39
SLC6A4 P31645 7/20 0.39
ALOX5AP P20292 4/20 0.36
FEN1 P39748 4/20 0.36
SMYD3 Q9H7B4 1/20 0.35
SLC6A1 P30531 2/20 0.34
SLC6A11 P48066 1/20 0.34
TSHR P16473 1/20 0.34
LMNA P02545 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
SLC6A13 Q9NSD5 1/20 0.34
SLC6A3 Q01959 5/20 0.34
CYP2D6 P10635 3/20 0.34
KCNH2 Q12809 2/20 0.34
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
NOS3 P29474 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1968845 0.88 SLC6A4 (0.48) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL20605786 0.88 SLC6A4 (0.48) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL20606457 0.88 SLC6A4 (0.48) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
Hydrochloric Acid SCHEMBL190820 0.86 SLC6A4 (0.47) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL13778879 0.79 SLC6A2 (0.32) SLC6A2SLC6A4
SCHEMBL15867020 0.77 ALDH1A1 (0.47) TSHRLMNASMN1; SMN2KDM4EKMT2A
SCHEMBL24242503 0.76 NOS2 (0.38) APLNRSLC6A2SLC6A4SLC6A1SLC6A11
SCHEMBL12362618 0.76 NOS2 (0.38) APLNRSLC6A2SLC6A4SLC6A1SLC6A11
SCHEMBL296911 0.75 SLC6A2 (0.39) SLC6A2SLC6A4SMYD3TSHRLMNA
SCHEMBL4972048 0.75 SLC6A1 (0.38) APLNRSLC6A2SLC6A4SLC6A1SLC6A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334662-A1 PYRINE OR PYRAZINE DERIVATIVES FOR TREATING HCV F. Hoffmann-La Roche AG (CH) 2011-06-22 EP disclosed
WO-2010034671-A1 PYRINE OR PYRAZINE DERIVATIVES FOR TREATING HCV F. HOFFMANN-LA ROCHE AG (CH) 2010-04-01 WO disclosed